Animal study · mice
CJC-1295 with DAC daily normalized growth in GHRH knockout mice
Checked against the paper Animal studyPublished by PepVault
The takeaway
In mice lacking GHRH, the same dose of CJC-1295 with DAC restored normal growth only when given daily, while longer gaps between doses worked less well.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2006
- Journal
- Am J Physiol Endocrinol Metab
What they tested
The team tested whether CJC-1295 with DAC could restore normal growth in mice bred to lack their own GHRH (growth hormone-releasing hormone), and how often it had to be given.
How the study was done
An animal study in GHRH knockout mice that started at 1 week old and were treated for 5 weeks with 2 microg of CJC-1295 with DAC every 24, 48 or 72 h. Knockout mice given placebo (a dummy treatment) and mice carrying one copy of the knocked-out gene were the comparison groups.

Model. Individual results vary.
What they found
In the knockout mice, daily dosing led to normal body weight and length. Mice dosed every 48 or 72 h grew heavier and longer than placebo-treated mice but did not fully catch up. Femur and tibia length stayed normal with dosing every 24 and 48 h, and relative lean mass and fat under the skin were normal in all treated groups. Treatment raised total pituitary RNA and growth hormone mRNA, and tissue staining pointed to growth in the number of growth hormone-making cells in the pituitary.
What it doesn’t show
This was done in young mice bred without their own GHRH, so it is not a result in people or in animals with normal hormone systems. Treatment lasted only 5 weeks.
The paper
Alba et al. Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse. Am J Physiol Endocrinol Metab. 2006.
The compound
More studies on CJC-1295 with DAC
- CJC-1295 with DAC: one shot raised GH 2- to 10-fold in healthy adultsRandomized trial · people · 2006
- CJC-1295 with DAC changed serum protein patterns in healthy menClinical trial · people · 2009
- CJC-1295 with DAC: trough GH up 7.5-fold, pulses kept in healthy menClinical trial · people · 2006
- CJC-1295 with DAC: 4-fold larger GH response than hGRF(1-29) in ratsAnimal study · rats · 2005
- Every study on CJC-1295 with DAC
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.